But also, FKBP51 antagonists, which were not yet tested in clinical samples, achieved very interesting findings in preclinical models of depression and anxiety; in addition, FKBP51 seems to be necessary for some effects exerted by ketamine [135]. Here, FKBP5 is linked to depressive disorder.